Compare Medpace Holdings Inc (MEDP) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Wipro Limited — how do they compare? Medpace Holdings Inc trades at $519.93 (market cap $15.08B), while Wipro Limited trades at $1.86 (market cap $18.49B). The key difference: Wipro Limited is the larger of the two by market cap, and Wipro Limited pays a 4.68% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | WIT | |
|---|---|---|
Market Cap | $15.08B | $18.49B |
Sector | Technology | Technology |
52-Week High | $620.59 | $3.06 |
52-Week Low | $308.88 | $1.82 |
Enterprise Value | $14.55B | $16.42B |
Dividend Yield | — | 4.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
WIT trades at $1.855, down 0.27% with bearish technical signals. Recent quarters show earnings misses against expectations, though 2025 revenue was $890.88B with net income of $131.35B. Valuation ratios appear reasonable with P/E of 13.97 and P/B of 1.96. Analyst consensus is mixed with 19% buy ratings amid concerns about client spending and AI investments.
The outlook remains cautious due to earnings volatility and competitive pressures. Investment appeal hinges on AI partnership execution and margin stabilization, while risks include geopolitical uncertainty and tech spending constraints. Cash flow strength provides some buffer against near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
